Annual report pursuant to Section 13 and 15(d)

Goodwill and Other Intangible Assets (Other Intangible Assets) (Details)

v3.3.1.900
Goodwill and Other Intangible Assets (Other Intangible Assets) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Acquired Finite-Lived Intangible Assets [Line Items]    
Goodwill $ 0 $ 15,545
Amortization of Intangible Assets 3,812 773
Finite-lived intangible assets, gross 47,468 47,468
Finite-Lived Intangible Assets, Accumulated Amortization (4,585) (773)
Finite-Lived Intangible Assets, Net $ 43,492 47,304
Diagnostic Test - Thyroid    
Acquired Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible asset, useful life 9 years  
Finite-Lived Intangible Assets, Net $ 8,519 8,519
Diagnostic Test - Pancreas    
Acquired Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible asset, useful life 7 years  
Finite-Lived Intangible Assets, Net $ 2,882 2,882
Biobank    
Acquired Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible asset, useful life 4 years  
Finite-Lived Intangible Assets, Net $ 1,575 1,575
Diagnostic Test - Pancreas RedPath [Member] [Member]    
Acquired Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible asset, useful life 7 years  
Finite-Lived Intangible Assets, Net $ 16,141 16,141
Diagnostic Test - Barrett's RedPath    
Acquired Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible asset, useful life 9 years  
Finite-Lived Intangible Assets, Net $ 18,351 18,351
CLIA Diagnostic Lab [Member]    
Acquired Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible asset, useful life 2 years 3 months  
Finite-Lived Intangible Assets, Net $ 609 $ 609